Completed NA INTERVENTIONAL 1-arm NCT03253003

Quality Control of CE-Certified Phonak Hearing Aids - 2017_27

Sponsor: Sonova AG

Conditions Hearing Loss, Bilateral Sensorineural, Progressive

Interventions Line extension of the Phonak Audéo B product family

Updated 6 times since 2017 Last updated: Sep 21, 2017 Started: Aug 7, 2017 Primary completion: Aug 25, 2017 Completion: Aug 25, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Hearing Loss, Bilateral Sensorineural, Progressive, this trial is completed. The trial is conducted by Sonova AG and has accumulated 6 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Oct 2017 — Jun 2018 [monthly]

Completed NA

Status: Active Not Recruiting → Completed

▶ Show 1 earlier version

Sep 2017 — Oct 2017 [monthly]

Active Not Recruiting NA

First recorded

Aug 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sonova AG

Data source: Sonova AG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stäfa, Switzerland